Now Live on OncLive: All 7 ESMO 2025 Review Episodes

Key Updates in Metastatic Uveal Melanoma

Watch the Full Series

Clinical Trials

Evaluation of the Safety and Efficacy of Treatment w/ High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/ Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/ Liver Dominant Disease

ClinicalTrials.gov ID: NCT06875128
Last updated: 2025-05-22

Learn more

Evaluation of the Safety and Efficacy of Treatment w/ High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/ approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/ liver Dominant Disease

ClinicalTrials.gov ID: NCT06607458
Last updated: 2024-09-23

Learn more

Active Clinical Trial Sites

Delcath continues to expand its clinical trial network across leading academic and cancer centers in the United States and Europe. The sites listed below are currently activated for our ongoing studies.

Metastatic Breast Cancer (MBC)

ClinicalTrials.gov ID: NCT06875128

United States

  • Moffitt Cancer Center — Tampa, FL

Europe

  • Clinic Barcelona — Barcelona, Spain

  • Helios Park-Klinikum Leipzig — Leipzig, Germany

  • IEO Milan — Milan, Italy

  • University Hospital — Czech Republic

Metastatic Colorectal Cancer (CRC)

ClinicalTrials.gov ID: NCT06607458

United States

  • City of Hope — Duarte, CA

  • University of Kansas Medical Center (KUMC) — Kansas City, KS

  • Moffitt Cancer Center — Tampa, FL

  • UCLA — Los Angeles, CA

  • Huntsman Cancer Institute — Salt Lake City, UT

Additional sites may be added as they complete activation.